We noted you are experiencing viewing problems
- 
        
        Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
 - 
        
        Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. - 
        
        No luck yet? More tips for troubleshooting viewing issues
 - 
        
        Contact HST Support access@hstalks.com
 
- 
        Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
 - 
        For additional help, please don't hesitate to contact HST support access@hstalks.com
 
We hope you have enjoyed this limited-length demo
                    
                    This is a limited length demo talk; you may
                    
                      login or
                    
                    review methods of
                    obtaining more access.
                  
                
                
              Printable Handouts
Navigable Slide Index
- Introduction
 - Outline
 - Introduction of resistance
 - Drug discovery process
 - Antibiotic resistance - two fundamental questions
 - Mechanisms of antibiotic action
 - Mechanisms of antibiotic resistance: efflux pumps
 - Modification of the antibiotic pharmacophore
 - Modification of the target structure
 - Targeting existing therapy and resistance
 - b-lactamase inhibition combined with antibiotic
 - Avoiding efflux pump mechanisms
 - Overcoming modification in the target structure (1)
 - Overcoming modification in the target structure (2)
 - Considerations and methods
 - Factors for consideration: target (genomic) based
 - Factors for consideration: whole cell based
 - Target (genomic) based approaches
 - "HIT" or "lead" discovery approaches
 - Fragment based drug discovery
 - HTS vs. fragment based approach
 - Modelling: ligand and structure known approach
 - The development of benzoylaminobenzolic acids
 - Modelling: structure known but ligand unknown
 - Discovery of bacterial MurD and MurE inhibitors
 - Modelling: ligand known but structure unknown
 - Virtual screening efforts
 - Target (genomic) based approaches: summary
 - Whole cell (empirical) based approaches
 - Selection of chemical starting points (1)
 - Selection of chemical starting points (2)
 - Discovery of a new class of anti-TB agent (1)
 - Discovery of a new class of anti-TB agent (2)
 - Whole cell based approaches: summary
 - General summary
 
Topics Covered
- Overview of the drug discovery process
 - Mechanisms of antibiotic action and resistance
 - Modification of the antibiotic pharmacophore
 - Modification of the target structure
 - Targeting existing therapy and resistance mechanisms
 - Overcoming modification in the target structure
 - Considerations and methods in the discovery of new antibiotics
 - Genomic based approaches
 - Lead discovery approaches
 - Fragment based drug discovery
 - Modelling: ligand and structure known approach
 - Modelling: structure known but ligand unknown approach
 - Modelling: ligand known but structure unknown
 - Whole cell (empirical) based approaches
 - Selection of chemical starting points
 
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Coxon, G. (2009, December 31). Medicinal chemistry strategies in combating antibiotic resistance [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 4, 2025, from https://doi.org/10.69645/JESX5069.Export Citation (RIS)
Publication History
- Published on December 31, 2009
 
Financial Disclosures
- Dr. Geoffrey Coxon has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.